AI-driven biotech research: Why China R&D matters

For more: https://www.cgtn.com/video If there's one thing we learned the hard way from the pandemic is how essential biotechnology is in saving millions of lives. From rapid advances in vaccines to cutting edge medical treatments, research and development investments have paid off. But, what's the result when biotech research gets a leg up from artificial intelligence? China has hosted these R&D efforts, and results could paint a better future in public health. What difference are they making? CGTN's Tian Wei asked Alex Zhavoronkov, the founder and CEO of Insilico Medicine. His company develops next-generation artificial intelligence and robotics platforms for drug discovery. Take a listen. Subscribe to us on YouTube: https://goo.gl/lP12gA Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8 Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv